HarrietOliviaSmithMD

Obstetrics & Gynecology • Bronx, NY

General Gynecology, Gynecologic Oncology, Urogynecology & Pelvic Reconstructive Surgery

Professor of Obsetrics and Gynecology, Chief of Gyn Oncology BronxCare Bronx Ny

Join to view full profile

Dr. Smith is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Smith's full profile

Already have an account?

Office
1650 Grand Concourse 5th floor Ob/gyn
Bronx Ny
Bronx, NY 10457
Phone+1 718-579-3953

Fax+1 718-239-8630

Summary

Dr. Harriet Smith is an obstetrician/gynecologist in Bronx, NY and is affiliated with multiple hospitals in the area, including NYC Health + Hospitals / Jacobi, BronxCare Health System, NYC Health + Hospitals / North Central Bronx, Montefiore Medical Center, St. Barnabas Hospital, and NYC Health + Hospitals / Coney Island. She received her medical degree from Medical College of Georgia School of Medicine and has been in practice 37 years. She specializes in general gynecology and gynecologic oncology and is experienced in general gynecology, gynecologic oncology, cytokines, gpr30, and spectroscopy.

Education & Training

Montefiore Medical Center/Albert Einstein College of MedicineFellowship, Gynecologic Oncology, 1989 - 1990
Emory University School of MedicineFellowship, Female Pelvic Medicine And Reconstructive Surgery (Obgyn), 1988 - 1989
University of Texas Health Science Center at HoustonResidency, Obstetrics and Gynecology, 1987 - 1988
Emory University School of MedicineResidency, Obstetrics and Gynecology, 1982 - 1986
Medical College of GeorgiaResidency, Family Medicine, 1981 - 1982
Medical College of GeorgiaResidency, Obstetrics and Gynecology, 1981 - 1981
Medical College of Georgia at Augusta UniversityClass of 1980

Certifications & Licensure

NY State Medical License 1991 - 2025
NM State Medical License 1988 - 2013
GA State Medical License 1982 - 1991
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Gynecologic Oncology

Awards, Honors, & Recognition

Top Doctors: New York Metro Area Castle Connolly, 2009-2014
America's Top Doctors Castle Connolly, 2003-2008
America's Top Doctors for Cancer Castle Connolly, 2005-2007
Top Doctors in Gynecologic Oncology Castle Connelly
Presidents Award, Society of Gynecologic Oncologists Society of Gynecologic Oncologists
Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Join now to see all

Clinical Trials

S9717 Tirapazamine Plus Cisplatin in Treating Patients With Metastatic, Recurrent, or Refractory Cervical Cancer Start of enrollment: 1998 Aug 01
Completed
Phase 2
S9912 Combination Chemo in Stage III Ovarian Cancer, Start of enrollment: 1999 Sep 01
Completed
Phase 2
Non-Invasive, Real-Time Technology for Diagnosis of Cervical Tissue Start of enrollment: 2004 Apr 01
Terminated
Not Applicable
Colony-Stimulating Factor-1 (CSF-1) and Other Cytokines in Human Endometrial Carcinogenesis Start of enrollment: 1998 Jan 01
Withdrawn
Pre-Clinical Models in Gynecological Tumors A Tissue Repository Start of enrollment: 2002 Jul 01
Completed
Scheduled Triple-lumen Central Venous Catheter Exchange: A Prospective Controlled Randomized Study Start of enrollment: 1994 Mar 01
Terminated
Not Applicable
Study of Adjuvant Topotecan and Cisplatin With Concurrent Radiation Therapy for Advanced Cervical Cancer Start of enrollment: 2002 Mar 01
Completed
Phase 1
SGO Society of Gynecologic Oncologists Data Outcomes Project Start of enrollment: 2002 Mar 01
Terminated
Differences in Trends Malignant Germ Cell Tumors in Males and Females: A SEER Population-based Study Start of enrollment: 2006 Jan 01
Withdrawn
Trends in Incidence and Survivals for Ovarian Germ Cell Tumors: A 27-Year Population-Based Study Start of enrollment: 2005 Dec 01
Withdrawn
Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Endometrial Cancer Start of enrollment: 2009 Jan 16
Terminated
Phase 2
Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With Uterine Cancer Start of enrollment: 2011 Jul 08
Terminated
Not Applicable
Join now to see all

Publications & Presentations

PubMed

5 citations
Utility of a custom designed next generation DNA sequencing gene panel to molecularly classify endometrial cancers according to The Cancer Genome Atlas subgroups.
E.M. Miller, Nicole E. Patterson, Gregory M. Gressel, Rouzan G. Karabakhtsian, Michal Bejerano-Sagie
BMC Medical Genomics. 2020-11-30
557 citations
Human Tumor-Associated Macrophage and Monocyte Transcriptional Landscapes Reveal Cancer-Specific Reprogramming, Biomarkers, and Therapeutic Targets.
Luca Cassetta, Stamatina Fragkogianni, Andrew H. Sims, Agnieszka Swierczak, Lesley M. Forrester
Cancer Cell. 2019-04-15
9 citations
Adjuvant Pelvic Radiation "Sandwiched" Between Paclitaxel/Carboplatin Chemotherapy in Women With Completely Resected Uterine Serous Carcinoma: Long-term Follow-up of a...
Marina Frimer, Eirwen M. Miller, Viswanathan Shankar, Eugenia Girda, Keyur J. Mehta
International Journal of Gynecological Cancer. 2018-11-01

Press Mentions

Explaining Face-Voice Matching Decisions: The Contribution of Mouth Movements, Stimulus Effects and Response BiasesApril 1st, 2021

Professional Memberships

American College of Obstetricians and Gynecologists
Fellow